BioGaia AB (publ) (BIOG_B) Q2 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Biogaia Ab Class B.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.318 -- 00:00:05.865 Hi, this is Teresa Agnew, CEO of BioGaia, and we are here to 00:00:05.865 -- 00:00:08.849 report on our Q2 2025 00:00:08.849 -- 00:00:10.711 results. 00:00:10.711 -- 00:00:16.198 For Q2, our sales were 405 million SEC, which represents growth of 5%. 00:00:16.198 -- 00:00:21.204 That was mainly due to higher sales in Americas, specifically North 00:00:21.204 -- 00:00:26.471 America and Asia Pacific. We did have growth of 13.2% 00:00:26.471 -- 00:00:30.592 when you exclude currency effects for the quarter. 00:00:30.592 -- 00:00:34.337 Sales in Europe, Middle East, Africa decreased by 1%. 00:00:34.337 -- 00:00:39.344 In Asia Pacific, sales increased by 15%. And in 00:00:39.344 -- 00:00:43.329 the Americas, sales increased by 5%. 00:00:43.329 -- 00:00:48.476 Our EBIT was 108 million SEC, which was a decrease of 20%. 00:00:48.476 -- 00:00:53.020 And our EBIT margin for the quarter was 27%. 00:00:53.102 -- 00:00:58.309 We also, over the period of Q2, announced that we are establishing direct 00:00:58.309 -- 00:01:00.848 sales in the Netherlands for the first time. 00:01:00.848 -- 00:01:05.175 This is a market in Europe where we never had bio Gaia sales. 00:01:05.175 -- 00:01:10.543 So this is a first for us where we have launched our business online. 00:01:10.543 -- 00:01:12.426 And I can talk about that a little bit more. 00:01:12.426 -- 00:01:18.495 I also wanted to mention first half sales were 771 million 00:01:18.495 -- 00:01:23.503 sec, which was growth of 2%. And that is growth of 5%, excluding 00:01:23.503 -- 00:01:25.773 the currency effects. 00:01:25.773 -- 00:01:29.958 Some of our launches over the quarter, you can see listed here where we launched our 00:01:29.958 -- 00:01:35.544 BioGaia Gastros product. We launched Protectus...